補足図 S5：メラノーマにおける補助免疫療法誘発免疫関連有害事象と関連する、基底免疫細胞におけるチロシンプロテインキナーゼ SYK 関連遺伝子シグネチャー

Monsonら（火曜日）はこの問題を研究しました。

www.synapsesocial.com/papers/68e56226e2b3180350efeef6 — DOI: https://doi.org/10.1158/1078-0432.27142336

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S3 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
2. Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
3. Supplementary Figure S2 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
4. Supplementary Figure S6 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024
5. Supplementary Figure S1 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma· 2024